Rhinomed announced it has entered into a distribution and supply agreement with The Linde Group and its Australian subsidiary BOC Limited. BOC will manage logistics and distribute Rhinomed's breathing technologies, Mute and Turbine, in the Australian and New Zealand markets. Rhinomed will ship product directly from its Hong Kong warehouse to BOC's logistics centre in Sydney. Under the arrangement, BOC will fulfill and supply all of Rhinomed's existing contracts within Australia - covering the existing 700 pharmacies currently stocking the product. BOC brings an extensive and highly experienced sales force to support the growing uptake of Rhinomed's products in the region. Mute complement's BOC's current sleep equipment offering that includes CPAP masks and supplies and in-home sleep studies, by providing an affordable, easy-to-use product for assisting with night-time nasal congestion and snoring.